Mitochondrial Respiratory Chain Enzyme Activities, mtDNA Variants and Gene Expression Levels in Idiopathic Parkinson's Disease

被引:0
作者
Ercan, Ayse [2 ]
Kulaksiz, Gulnihal [1 ]
Dalmizrak, Ozlem [1 ,3 ]
Muftuoglu, Meltem [1 ]
Ogus, Hamdi [1 ]
Cavdar, Leyla [4 ]
Inan, Levent [4 ]
Ozer, Nazmi [1 ,3 ]
机构
[1] Hacettepe Univ, Fac Med, Dept Biochem, TR-06100 Ankara, Turkey
[2] Hacettepe Univ, Fac Pharm, Dept Biochem, TR-06100 Ankara, Turkey
[3] Near East Univ, Fac Med, Dept Basic Med Sci, TR-10 Nicosia, Mersin, Turkey
[4] Ankara Res & Training Hosp, Dept Neurol, TR-06100 Ankara, Turkey
来源
TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI | 2009年 / 34卷 / 02期
关键词
Idiopathic PD; Complex I; glutathione; ND2; ND4; COMPLEX-I ACTIVITY; SKELETAL-MUSCLE; GLUTATHIONE DEPLETION; DNA; DYSFUNCTION; INHIBITION; MUTATIONS; PLATELETS; BRAIN;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Purpose: Mitochondrial dysfunction has been implicated in the development of idiopathic Parkinson's disease. In this study, it was aimed to investigate the relationship between mitochondrial respiratory chain enzyme deficiency and variants in ND2 and ND4 region of Complex I and expressions of these genes. Complex IV activity and glutathione level were also studied. Methods: Activities of Complex I, Complex IV, citrate synthase and glutathione levels were measured from muscle biopsy samples of 19 idiopathic Parkinson's Disease patients. Entire ND2 and ND4 regions of Complex I were screened by sequencing and expression levels of these regions were also examined by using relative quantitative RT-PCR. Results: A significant decrease in Complex I and IV activities was found in Parkinson's Disease patients (19.73 +/- 8.24 U/mg protein, 11.51 +/- 6.45 U/mg protein) compared with the control group (31.48 +/- 8.28 U/mg protein, 30.02 +/- 14.76 U/mg protein), respectively. Although several sequence variants were detected in ND2 and ND4 genes, they didn't account for the decrease in Complex I activity. ND2 (19 % and 21 %) and ND4 (14 % and 13 %) mRNA expressions were reduced in two of 19 patients. Conclusion: Taken together, Complex I and IV dysfunctions and mitochondrial abnormalities might be the result of oxidative stress contributing to the pathogenesis of idiopathic Parkinson's Disease since we found that reduced glutathione levels were decreased 47 % in these patients.
引用
收藏
页码:97 / 104
页数:8
相关论文
共 50 条
  • [21] Accumulation of mitochondrial 7S DNA in idiopathic and LRRK2 associated Parkinson's disease
    Podlesniy, Petar
    Puigros, Margalida
    Serra, Nuria
    Fernandez-Santiago, Ruben
    Ezquerra, Mario
    Tolosa, Eduardo
    Trullas, Ramon
    EBIOMEDICINE, 2019, 48 : 554 - 567
  • [22] Gene therapy targeting mitochondrial pathway in Parkinson's disease
    Choong, Chi-Jing
    Mochizuki, Hideki
    JOURNAL OF NEURAL TRANSMISSION, 2017, 124 (02) : 193 - 207
  • [23] Delta deletion 4977 in mitochondrial DNA in patients with idiopathic Parkinson's disease
    Taravari, A.
    Panov, S.
    Petrov, I
    Petrova, V
    Medziti, F.
    Haliti, G.
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2014, 115 (01): : 7 - 13
  • [24] Comparison of mitochondrial respiratory chain enzyme activities in rodent astrocytes and neurones and a human astrocytoma cell line
    Stewart, VC
    Land, JM
    Clark, JB
    Heales, SJR
    NEUROSCIENCE LETTERS, 1998, 247 (2-3) : 201 - 203
  • [25] Prevalence of parkin gene mutations and variations in idiopathic Parkinson's disease
    Sinha, R
    Racette, B
    Perlmutter, JS
    Parsian, A
    PARKINSONISM & RELATED DISORDERS, 2005, 11 (06) : 341 - 347
  • [26] Mitochondrial Gene Therapy Augments Mitochondrial Physiology in a Parkinson's Disease Cell Model
    Keeney, Paula M.
    Quigley, Caitlin K.
    Dunham, Lisa D.
    Papageorge, Christina M.
    Iyer, Shilpa
    Thomas, Ravindar R.
    Schwarz, Kathleen M.
    Trimmer, Patricia A.
    Khan, Shaharyar M.
    Portell, Francisco R.
    Bergquist, Kristen E.
    Bennett, James P., Jr.
    HUMAN GENE THERAPY, 2009, 20 (08) : 897 - 907
  • [27] Relationship between brain iron deposition and mitochondrial dysfunction in idiopathic Parkinson's disease
    Prasuhn, Jannik
    Goettlich, Martin
    Gerkan, Friederike
    Kourou, Sofia
    Ebeling, Britt
    Kasten, Meike
    Hanssen, Henrike
    Klein, Christine
    Brueggemann, Norbert
    MOLECULAR MEDICINE, 2022, 28 (01)
  • [28] Mitochondrial DNA variants modulate genetic susceptibility to Parkinson's disease in Han Chinese
    Wu, Hong-Mei
    Li, Ting
    Wang, Zhen-Feng
    Huang, Shi-Shi
    Shao, Zi-Qiang
    Wang, Ke
    Zhong, Hai-Qing
    Chen, Song-Fang
    Zhang, Xiong
    Zhu, Jian-Hong
    NEUROBIOLOGY OF DISEASE, 2018, 114 : 17 - 23
  • [29] mRNA expression profiling of mitochondrial subunits in subjects with Parkinson's disease
    Salemi, Michele
    Cosentino, Filomena
    Lanza, Giuseppe
    Cantone, Mariagiovanna
    Salluzzo, Maria Grazia
    Giurato, Giorgio
    Borgione, Eugenia
    Marchese, Giovanna
    Santa Paola, Sandro
    Lanuzza, Bartolo
    Romano, Corrado
    Ferri, Raffaele
    ARCHIVES OF MEDICAL SCIENCE, 2023, 19 (03) : 678 - 686
  • [30] Astrocytic Changes in Mitochondrial Oxidative Phosphorylation Protein Levels in Parkinson's Disease
    Chen, Chun
    Mossman, Emily
    Malko, Philippa
    McDonald, David
    Blain, Alasdair P.
    Bone, Laura
    Erskine, Daniel
    Filby, Andrew
    Vincent, Amy E.
    Hudson, Gavin
    Reeve, Amy K.
    MOVEMENT DISORDERS, 2022, 37 (02) : 302 - 314